Circulating OPN level was selected as a biomarker for the acute exacerbation of chronic obstructive pulmonary disease (COPD) [70] and the severity of coronavirus disease 2019 (COVID-19) [71]. The gene discussed is SPP1; the disease is glycogen storage disease VI.